Glaucoma, one of the leading causes of global blindness, affects nearly 2.5 million Americans. Early diagnosis and treatment can minimize or prevent optic nerve damage and limit glaucoma-related vision loss. It is important for practicing ophthalmologists to become updated on advances in diagnostic, medical, and surgical treatments for glaucoma to improve patient outcomes.
There are several established classes of medications that are effective in reducing intraocular pressure by improving aqueous outflow, reducing the production of aqueous, or both. In addition, clinical trials are being conducted on certain neuroprotective drugs to determine if they may help to protect the optic nerve from damage associated with glaucoma.
Surgical treatments for glaucoma include laser surgery (trabeculoplasty) and filtering surgery (trabeculectomy), as well as newer procedures that removes a targeted strip of trabecular meshwork with electrocautery and drainage implant surgery. All of these surgical techniques undergo continuous refinement, and ophthalmologists benefit from updates on these new techniques. Education on advances in glaucoma imaging, as well as updates on emerging research concerning basic science, clinical research and clinical trials of new medications is important for practicing ophthalmologists as well.
This course is designed to educate clinicians regarding innovative techniques to improve care to patients afflicted with this disease, and the specific topics were determined through a review of the topics requested by attendees at previous years’ sessions of the annual Yale Glaucoma Symposium as well as the course director's extensive knowledge of advances in the field. Yale School of Medicine and Department of Visual Sciences, as a tertiary care referral academic medical center and regional resource for education and treatment of eye diseases, is in a premier position to provide this needed education to a broad audience of practicing ophthalmologists.
Learning Objectives
Participants who attend this conference will be able to:
-
State recent technological advances in surgical treatment of glaucoma.
-
Describe new diagnostic and therapeutic advances that have implications for care of patients with glaucoma
-
Elucidate the types of imaging that are useful for diagnosis of glaucoma
-
Define the optimal IOP range for patients with glaucoma
-
Determine the most efficacious therapy for glaucoma based on patient presentation.
-
Describe current research leading to new and potential future treatments for glaucoma
Friday, November 6, 2009
8 AMA PRA Category 1 CreditsTM
New York Academy of Medicine
1216 5th Avenue
New York, NY
Registration Fees
Registration fee includes all conference materials, continental breakfast, refreshment breaks and lunch.
Physicians - $195
Nurses/PAs/Allied Health Professionals - $95
Residents/Fellows*-$25
Yale Eye Center Staff - Complimentary
*A letter of verification from department head must accompany registration. If registering online, letter should be sent separately to Yale CME address below.
All cancellations must be received in writing (or via email) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.
Center for Continuing Medical Education
P.O. Box 7619
New Haven, CT
06519
Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit.
Designation Statement
The Yale School of Medicine designates this educational activity for a maximum of 8 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating as speakers in these programs are required to disclose any relevant financial relationship(s) they (or spouse or partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. The Center for Continuing Medical Education will ensure that any conflicts of interest are resolved before the educational activity occurs.
.
